431 related articles for article (PubMed ID: 22682188)
41. Nodular lesions of the buttock for 20 years: the challenge of chromoblastomycosis in non-endemic settings.
Osborne W; Langman G; Ladoyanni E; Chue A
BMJ Case Rep; 2024 Mar; 17(3):. PubMed ID: 38490708
[TBL] [Abstract][Full Text] [Related]
42. Chromoblastomycosis: clinical and mycologic experience of 51 cases.
Bonifaz A; Carrasco-Gerard E; Saúl A
Mycoses; 2001; 44(1-2):1-7. PubMed ID: 11398635
[TBL] [Abstract][Full Text] [Related]
43. Case report. A case of chromoblastomycosis effectively treated with terbinafine. Characteristics of chromoblastomycosis in the Kitasato region, Japan.
Tanuma H; Hiramatsu M; Mukai H; Abe M; Kume H; Nishiyama S; Katsuoka K
Mycoses; 2000; 43(1-2):79-83. PubMed ID: 10838854
[TBL] [Abstract][Full Text] [Related]
44. Chromoblastomycosis in the Amazon region, Brazil, caused by Fonsecaea pedrosoi, Fonsecaea nubica, and Rhinocladiella similis: Clinicopathology, susceptibility, and molecular identification.
de Andrade TS; de Almeida AMZ; Basano SA; Takagi EH; Szeszs MW; Melhem MSC; Albuquerque M; Camargo JSAA; Gambale W; Camargo LMA
Med Mycol; 2020 Feb; 58(2):172-180. PubMed ID: 31329924
[TBL] [Abstract][Full Text] [Related]
45. Chromoblastomycosis in Sarawak, East malaysian Borneo.
Yap FB
Trans R Soc Trop Med Hyg; 2010 Feb; 104(2):168-9. PubMed ID: 19766279
[TBL] [Abstract][Full Text] [Related]
46. Chromoblastomycosis in India: Review of 169 cases.
Agarwal R; Singh G; Ghosh A; Verma KK; Pandey M; Xess I
PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005534. PubMed ID: 28771470
[TBL] [Abstract][Full Text] [Related]
47. [Fonsecaea pedrosoi-induced chromoblastomycosis: about a case].
Baline K; Hali F
Pan Afr Med J; 2018; 30():187. PubMed ID: 30455816
[TBL] [Abstract][Full Text] [Related]
48. Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi.
Queiroz-Telles F; Purim KS; Fillus JN; Bordignon GF; Lameira RP; Van Cutsem J; Cauwenbergh G
Int J Dermatol; 1992 Nov; 31(11):805-12. PubMed ID: 1330949
[TBL] [Abstract][Full Text] [Related]
49. Chromoblastomycosis in a resident of a leprosarium.
Dashatwar D; Kar S; Gangane N; Pol V; Madke B; Kulkarni S; Singh N
Lepr Rev; 2015 Mar; 86(1):102-7. PubMed ID: 26065153
[TBL] [Abstract][Full Text] [Related]
50. Chromoblastomycosis.
Yap FB
Int J Infect Dis; 2010 Jun; 14(6):e543-4. PubMed ID: 19889559
[No Abstract] [Full Text] [Related]
51. Management of chromoblastomycosis: novel perspectives.
Esterre P; Queiroz-Telles F
Curr Opin Infect Dis; 2006 Apr; 19(2):148-52. PubMed ID: 16514339
[TBL] [Abstract][Full Text] [Related]
52. In vitro susceptibility of chromoblastomycosis agents to five antifungal drugs and to the combination of terbinafine and amphotericin B.
Daboit TC; Massotti Magagnin C; Heidrich D; Czekster Antochevis L; Vigolo S; Collares Meirelles L; Alves K; Scroferneker ML
Mycoses; 2014 Feb; 57(2):116-20. PubMed ID: 23895037
[TBL] [Abstract][Full Text] [Related]
53. Extensive long-standing chromomycosis due to Fonsecaea pedrosoi: three cases with relevant improvement under voriconazole therapy.
Criado PR; Careta MF; Valente NY; Martins JE; Rivitti EA; Spina R; Belda W
J Dermatolog Treat; 2011 Jun; 22(3):167-74. PubMed ID: 20666671
[TBL] [Abstract][Full Text] [Related]
54. Effect of Melanin Biosynthesis Inhibition on the Antifungal Susceptibility of Chromoblastomycosis Agents.
Heidrich D; Pagani DM; Koehler A; Alves KO; Scroferneker ML
Antimicrob Agents Chemother; 2021 Jul; 65(8):e0054621. PubMed ID: 33972246
[TBL] [Abstract][Full Text] [Related]
55. Parenteral vitamin D(3) and oral terbinafine for refractory chromoblastomycosis.
Hussain I; Rashid T; Haroon TS
Br J Dermatol; 2002 Apr; 146(4):704. PubMed ID: 11966710
[No Abstract] [Full Text] [Related]
56. Treatment of chromoblastomycosis with terbinafine: a report of four cases.
Xibao Z; Changxing L; Quan L; Yuqing H
J Dermatolog Treat; 2005 Apr; 16(2):121-4. PubMed ID: 16019628
[TBL] [Abstract][Full Text] [Related]
57. Cutaneous Chromoblastomycosis Caused by Veronaea botryosa in a Patient with Pemphigus Vulgaris and Review of Published Reports.
Zhu CY; Yang YP; Sheng P; Li W; Huang WM; Fan YM
Mycopathologia; 2015 Aug; 180(1-2):123-9. PubMed ID: 25821930
[TBL] [Abstract][Full Text] [Related]
58. Wide Morphologic Variability of Chromoblastomycosis in the Western Hemisphere.
Mugleston BJ; Usatine RP; Rosen T
Skinmed; 2016; 14(6):423-427. PubMed ID: 28031127
[TBL] [Abstract][Full Text] [Related]
59. Case Report: A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi in Vietnam.
Le TA; Nguyen KL; Pham MH; Vi TT; Do NA
Mycopathologia; 2019 Feb; 184(1):115-119. PubMed ID: 29974323
[TBL] [Abstract][Full Text] [Related]
60. Case report: Fever- pneumonia- lymphadenectasis- osteolytic- subcutaneous nodule: Disseminated chromoblastomycosis caused by phialophora.
Qiu Y; Zhang J; Tang Y; Zhong X; Deng J
J Infect Chemother; 2019 Dec; 25(12):1031-1036. PubMed ID: 31229375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
